期刊文献+

用群体药代动力学模型实现抗生素个体化给药 被引量:2

The Application of Population Pharmacokinetic Model to Individualized Antibiotic Therapy
下载PDF
导出
摘要 目的:介绍群体药代动力学模型在抗生素调整剂量上的应用。方法:群体药代动力学模型以及药代动力学(PK)-药效动力学(PD)模型的基本概念、建立步骤、应用特点以及国内外发展现状。并通过两个举例说明剂量调试方法。结果与结论:群体药代动力学和TDM监测紧密联系用于临床抗感染治疗,PK-PD模型的应用有利于临床药学的剂量设计和剂量调整,为不同患者群体的抗感染治疗的最合理解释。 OBJECTIVE: To introduce the application of population pharmacokinetic model to dose - adjustment of antibiotics. METHODS: To analyze basic concepts of population pharmacokinetic model and pharmacokinetic (PK) - pharmacodynamic(PD) model, set up the procedure and study applicational characters and development status at home and abroad, two examples were given for explaining dose - adjustment method. RESULTS&CONCLUSION: Close combination of population pharmacokinetics and therapeutic drug monitoring can be applied to anti - infective therapy in the clinic. The use of PK- PD model will be beneficial to dose design and adjustment in clinical pharmacy, it will also make most rational explanations for different patient population in anti - infective therapy.
出处 《中国医院用药评价与分析》 2006年第1期49-52,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 群体药代动力学 药代动力学(PK)-药效动力学(PD)模型 抗生素 population pharmacokinetics pharmacokinetic-pharmacodynamic antibiotics
  • 相关文献

参考文献16

  • 1魏树理,张强主编.生物药剂学与药代动力学[M].第3版.北京:北京大学医学出版社,1999.
  • 2姜德春,王丽.群体药代动力学及其儿科应用[J].儿科药学杂志,2004,10(1):5-8. 被引量:4
  • 3Sheine LB.Modeling of pharmacokinetics and phamlacodynamics:Application to d-tubocurarine[J].Clin Pharmacol Ther,1979,25:358.
  • 4Center for Drug Evaluation Research.Guidance for industry:Population pharmacokinetics:DRAFT GUIDANCE,United States Department of Health and Human Service[EB].Food and Drug Administration:1997.
  • 5Davidian M,Giltinan DM.Some general estimation methods for nonlinear mixed-effectes models[J].Journal of Biopharmaceutical Statistics,1993,3 (1):23.
  • 6Van Lent-Evers NA,Mathot RA,Geus WP,et al.Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcomes[J].The Drug Monit,1999,21(1):63.
  • 7Alexander A,Vinks.The application of population pharmacokinetic modeling to individualized antibiotic therapy[J].Int J Anti Agents,2002,19:313.
  • 8Van Dalen R,Vree TB,Baars AM,et al.Dosage adjustment for ceftazidime in patients with inpaired renal function[J].Eur J Clin Pharmacol,1986,30(5):597.
  • 9Sheiner L,Wakefield J.Population modeling in drug development[J].Stat Methods Med Res,1999,8(3):183.
  • 10Rodvold KA.Pharmacodynamics of antiinfective therapy:taking what we know to the patient' s besides[J].P.harmacotherapy,2001,21 (11 Pt 2):319 s.

二级参考文献6

共引文献3

同被引文献42

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部